Inclusion in neurological research: empowering people living with neurological diseases
- PMID: 39774246
- DOI: 10.1038/s41582-024-01047-6
Inclusion in neurological research: empowering people living with neurological diseases
Abstract
The value of involving people living with diseases in the research process is increasingly recognized by professional associations and regulatory agencies alike. Patient contributions range from disease prevention and diagnosis to medication planning, and from advocacy to guideline production and clinical trial design. Thanks to the efforts of activists and advocates, new models of patient inclusion in medical research are being developed to replace outdated non-participative and tokenistic paradigms. New modalities of patient participation in research - for example, the introduction of patient experts, who work closely with researchers and clinicians - have progressively empowered individuals who are living with diseases. In this Perspective, we provide an overview of the current status of patient involvement in medical research, with a specific focus on neurology. We also discuss the existing and future roles of patient experts in neurological research.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: M.T.F. is the co-founder of the Women’s Brain Project. In the past 2 years she has received consulting and speaking fees from Roche, Angelini Pharma and Prodeco Pharma unrelated to this project. She is currently the Clinical Development Lead of Syntropic Medical. M.U. has received honoraria for consulting services from Alexion, Janssen, Merck, UCB Pharma and UCB S.A., and speaking fees from Alexion and UCB S.A.. She also provided consulting services to Argenx. Travel expenses for congresses were paid by Alexion, UCB Pharma, UCB S.A. and Argenx. R.F. is the co-founder and chief executive officer of My Moves Matter. E.M. has received restricted research grant support from Abbott and France Parkinson. She has also received honoraria from Medtronic for consultation services. I.L. declares advisory boards and honoraria for talks from Roche, NovoNordisk, Eli Lilly and Boehringer.
References
-
- World Health Organization. Health 2020: A European Policy Framework and Strategy for the 21st Century (WHO, 2013).
-
- National Institute for Health and Care Research. Briefing notes for researchers - public involvement in NHS, health and social care research. https://www.nihr.ac.uk/documents/briefing-notes-for-researchers-public-i... (2024).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
